Psoriasis trials in Australia

In Australia 7 Also abroad 274

7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Nedlands, South Brisbane, Westmead
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
Phase 3Taking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Carlton, Clayton, Darlinghurst, East Melbourne, Greenslopes, Kogarah, Westmead, Woolloongabba
Age
40 years and over
People
3,040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
Phase 1Taking people
A Clinical Trial of MK-8644 in Healthy Participants and Participants With Psoriasis (MK-8644-001)
Where
Melbourne
Age
18 years to 65 years
People
132
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07850310
Phase 3Taking people
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Brisbane, Clayton, Darlinghurst, Melbourne, Westmead, Woolloongabba
Age
4 years to 18 years
People
153 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04772079 · EU 2022-502519-13-00
Phase 3Taking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Victoria Park
Age
18 years and over
People
1,182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
Phase 3Taking people
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Where
Clayton
Age
5 years to 17 years
People
40 worldwide
Run by
AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00
Phase 1Taking people
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Where
Birtinya, Charlestown
Age
18 years to 75 years
People
24
Run by
Seismic Therapeutic AU Pty Ltd
See details and how to joinNCT07455578